Fatal rhabdomyolysis as a complication of ET-743 (Yondelis) chemotherapy for sarcoma

Autor:	Amy, Skorupa, Matthew, Beldner, Andrew, Kraft, Alberto J, Montero
Rok vydání:	2007
Předmět:	Male Fatal Outcome Tetrahydroisoquinolines Humans Sarcoma Dioxoles Middle Aged Antineoplastic Agents Alkylating Rhabdomyolysis Trabectedin
Zdroj:	Cancer biologytherapy. 6(7)
ISSN:	1538-4047
Popis:	Rhabdomyolysis is a clinical syndrome in which skeletal muscle damage and necrosis leads to the release of intracellular muscle contents, which can ultimately lead to electrolyte disturbances, renal failure and even death. Chemotherapy is an extremely rare cause of rhabdomyolysis. Herein, we describe a fatal case of rhabdomyolysis in a patient with metastatic sarcoma after receiving the chemotherapeutic agent Ecteinascidin-743 (ET-743, trabectedin) as palliative chemotherapy treatment.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::6910c77856c50fcb467069f074a833fa https://pubmed.ncbi.nlm.nih.gov/17611408 Zobrazit plný text záznamu